Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial.
暂无分享,去创建一个
J. Bruix | R. Lencioni | J. Llovet | G. Meinhardt | Jiamei Yang | G. Han | W. Tak | M. Leberre | W. Niu | Kate Nicholson